Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of COVID-19 on patients with metastatic breast cancer: REthink aAccess to Care and Treatment survey results
    Journal Article

    Iyengar, N. M.; Williams, C.; Rogan, M.; Campbel, L.; Mertz, S.; Block, J.; Ebling, M.; Chen, C.; Doan, J.; Kurosky, S. K.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
    Journal Article

    Mai, N.; dos Anjos, C. H.; Razavi, P.; Safonov, A.; Patil, S.; Chen, Y.; Drago, J. Z.; Modi, S.; Bromberg, J. F.; Dang, C. T.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2− breast cancer
    Journal Article

    Elias, A. D.; Staley, A. W.; Fornier, M.; Vidal, G. A.; Alami, V.; Sams, S.; Spoelstra, N. S.; Goodspeed, A.; Kabos, P.; Diamond, J. R.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Journal Article

    Roychowdhury, T.; McNutt, S. W.; Pasala, C.; Nguyen, H. T.; Thornton, D. T.; Sharma, S.; Botticelli, L.; Digwal, C. S.; Joshi, S.; Yang, N.; more...
    Nature Communications (2024)

    Fulltext@MSK | Save
  • Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study
    Journal Article

    Yonemori, K.; Boni, V.; Min, K. G.; Meniawy, T. M.; Lombard, J.; Kaufman, P. A.; Richardson, D. L.; Bender, L.; Okera, M.; Matsumoto, K.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Intermittent MEK inhibition with GITR costimulation rescues T-cell function for increased efficacy with CTLA-4 blockade in solid tumor models
    Journal Article

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mangarin, L. M.; Nevarro, V. E.; Mehanna, N.; Khan, J. F.; Venkatesh, D.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel
    Journal Article

    Trager, M. H.; Kuo, A. M.; Dusza, S. W.; Park, V.; Geskin, L.; Guyer, A.; Abuhadra, N.; Gucalp, A.; Lacouture, M. E.
    Archives of Dermatological Research (2024)

    Fulltext@MSK | Save
  • Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC)
    Meeting Abstract

    Loi, S.; Johnston, S. R. D.; Arteaga, C. L.; Graff, S. L.; Chandarlapaty, S.; Goetz, M. P.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Managed care considerations in the treatment of HER2-positive advanced breast cancer: A closer look at recent advances for improved patient outcomes
    Journal Article

    Modi, S.
    Journal of Managed Care Medicine (2024)

    Fulltext@MSK | Save